Picture EBD Group ChinaBio Partnerting Forum 2021 651x80
Document › Details

PharmaLex GmbH. (8/1/20). "Press Release: PharmaLex Strengthens Its Commercial Organization". Frankfurt.

Organisations Organisation PharmaLex GmbH
  Group PharmaLex (Group)
  Organisation 2 ProductLife AG (CH)
  Group ProductLife Group (Group)
Products Product regulatory services
  Product 2 drug development services
Persons Person Schmitt, Sébastian (PharmaLex 202008– Group CCO + Managing Director Switzerland before ProductLife Group)
  Person 2 Dobmeyer, Thomas (PharmaLex 202010 Managing Director)

The appointment of Sébastien Schmitt will further consolidate PharmaLex’s commercial offerings for our clients.

PharmaLex Group, a leading provider of specialized services for pharma, biotech and medical device industries worldwide, is pleased to welcome Sébastien Schmitt as a valuable addition to our senior management team.

Sébastien joins PharmaLex as Chief Commercial Officer where he will oversee all aspects of PharmaLex commercial activities, ensuring that our clients benefit from a truly integrated service offering.

Through his role, he will ensure that PharmaLex further strengthens the commercial fundamentals, strategy, operations and a team dynamic that will be designed to grow with our clients’ needs and provide the best possible solution globally and regionally. Besides this key focus, he will also develop the PharmaLex Swiss country organization as its Managing Director. His vast experience in sales and marketing and his solid track record in delivering tailored service solutions, especially to multi-national clients, will be a timely enrichment to our organization.

Sébastien joins PharmaLex following nearly a decade with ProductLife Group, where he headed the delivery and commercial organization.

“I am very excited to join a growing organization like PharmaLex”, explained Sébastien. “Their reputation as a leader in specialized services for the life science industry is well known and their global footprint presents excellent opportunities to provide real added value to their clients”, he commented.

“We are extremely pleased that Sébastien is joining us to head and further shape our commercial organisation. His ability to deliver customer-focused and results-oriented solutions was key during the selection process”, explained Dr. Thomas Dobmeyer, CEO PharmaLex. “Furthermore, we have seen a very positive development in the entire DACH region and strengthening our location in Switzerland will be of particular strategic importance, ensuring that our services can be expanded to the hotspot of the Swiss pharmaceutical industry”, he added.


About PharmaLex :

PharmaLex is a leading provider of specialised services for the pharma, biotech and medical device industries. We guide you from early strategic planning activities and non-clinical requirements through clinical development, regulatory submission processes and post-approval / maintenance post-launch activities. Our experts use technology-enabled solutions to support you through the entire product lifecycle. We deliver exceptional results — going above and beyond the standard to deliver tailor-made solutions worldwide.

The PharmaLex Group now has over 1000 employees, with 34 offices in 21 countries and more than 600 satisfied clients worldwide.

For further information, please contact:

Ms. Eva Keck
PharmaLex GmbH; Director, Business Development Operations
+49 621 18 15 38 0
Harrlachweg 6
68163 Mannheim

Record changed: 2020-10-27


Picture Kentro Design Corporate and Web Design Berlin 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group ChinaBio Partnerting Forum 2021 651x80

» top